BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19828692)

  • 1. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy.
    Vannucchi G; Perrino M; Rossi S; Colombo C; Vicentini L; Dazzi D; Beck-Peccoz P; Fugazzola L
    Eur J Endocrinol; 2010 Jan; 162(1):145-51. PubMed ID: 19828692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
    Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
    Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid cancer in pregnancy: a report of 3 cases.
    Chong KM; Tsai YL; Chuang J; Hwang JL; Chen KT
    J Reprod Med; 2007 May; 52(5):416-8. PubMed ID: 17583242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of differentiated thyroid cancer diagnosed in pregnant women.
    Moosa M; Mazzaferri EL
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2862-6. PubMed ID: 9284711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing of surgery in well-differentiated thyroid carcinoma detected during pregnancy.
    Nam KH; Yoon JH; Chang HS; Park CS
    J Surg Oncol; 2005 Sep; 91(3):199-203. PubMed ID: 16118775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy as a risk factor for thyroid cancer progression.
    Rakhlin L; Fish S
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):326-329. PubMed ID: 29965867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid cancer and pregnancy].
    Vinatier D; Cosson M; Proye C; Patey-Savatier P; Monnier JC
    Rev Fr Gynecol Obstet; 1989 Dec; 84(12):919-22. PubMed ID: 2696064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk.
    Magri F; Capelli V; Rotondi M; Leporati P; La Manna L; Ruggiero R; Malovini A; Bellazzi R; Villani L; Chiovato L
    Endocr Relat Cancer; 2012 Aug; 19(4):463-71. PubMed ID: 22531679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer.
    Hirsch D; Levy S; Tsvetov G; Weinstein R; Lifshitz A; Singer J; Shraga-Slutzky I; Grozinski-Glasberg S; Shimon I; Benbassat C
    Thyroid; 2010 Oct; 20(10):1179-85. PubMed ID: 20860423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer.
    Vannucchi G; De Leo S; Perrino M; Rossi S; Tosi D; Cirello V; Colombo C; Bulfamante G; Vicentini L; Fugazzola L
    Eur J Endocrinol; 2015 Jul; 173(1):29-36. PubMed ID: 25862786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and obstetrical outcome in 35 cases of well-differentiated thyroid carcinoma during pregnancy.
    Boucek J; de Haan J; Halaska MJ; Plzak J; Van Calsteren K; de Groot CJM; Dahl Steffensen K; Fruscio R; Massolt ET; Klaritsch P; Zola P; Amant F;
    Laryngoscope; 2018 Jun; 128(6):1493-1500. PubMed ID: 28988434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
    Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to the pregnant patient with thyroid cancer.
    Mazzaferri EL
    J Clin Endocrinol Metab; 2011 Feb; 96(2):265-72. PubMed ID: 21296990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and treating thyroid nodules and cancer before, during, and after pregnancy: a patient's guide.
    De Groot LJ; Mestman J
    J Clin Endocrinol Metab; 2012 Nov; 97(11):37A-8A. PubMed ID: 23129600
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thyroid cancer and pregnancy (literature review and a case report)].
    Mathieu E; Dufour P; Vinatier D; Vanderstichele S; Puech F; Carnaille B
    Contracept Fertil Sex; 1997 Sep; 25(9):681-7. PubMed ID: 9410390
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
    Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
    Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary carcinoma of the thyroid occurring during pregnancy. Report of a case diagnosed by fine needle aspiration cytology.
    Fukuda K; Hachisuga T; Sugimori H; Tsuzuku M
    Acta Cytol; 1991; 35(6):725-7. PubMed ID: 1950324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity.
    Wong RL; Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Aug; 19(8):2635-42. PubMed ID: 22526904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive effect of fetal cell microchimerism on tumor presentation and outcome in papillary thyroid cancer.
    Cirello V; Fugazzola L
    Chimerism; 2014; 5(3-4):106-8. PubMed ID: 26646628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.